CB2 Insights (CSE: CBII) (OTCQB: CBIIF) has agreed to assist VIVO Cannabis (TSX-V: VIVO) (OTCQX: VVCIF) in the development of VIVO’s global medical product development strategy. Under a technology and multi-phase research agreement, CB2 will be integrating its Clinical Data Management Software (CDMS) and Electronic Data Capture (EDC) tools to establish a better understanding of VIVO’s current […]The post VIVO Partners CB2 Insights to Create Global Cannabis Product Strategy appeared first on Market Exclusive. …read more
Source:: Yahoo Finance
